Type of security: Fund
The data is delayed by 15 minutes.
Description: The investment seeks investment results that, before fees and expenses, correspond generally to the total return performance of an index. The fund employs a sampling strategy in seeking to track the performance of the S&P Developed Ex-U.S. BMI Index. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index or in ADRs or GDRs based on securities comprising the index. The index is a market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in developed countries outside the United States. The fund is non-diversified.
|High 52 week||31.16||Low 52 week||24.51||Last close||31.16||Last change||-0%|
|RSI||83.4||Average true range||2.36||Beta||1.01||Volume||49.98 K|
|Simple moving average 20 days||1.55%||Simple moving average 50 days||3.19%||Simple moving average 200 days||9.53%|
|Performance Week||1.79%||Performance Month||2.56%||Performance Quart||5.14%||Performance Half||14.42%|
|Performance Year||24.09%||Performance Year-to-date||22.74%||Volatility daily||0.34%||Volatility weekly||0.76%|
|Volatility monthly||1.55%||Volatility yearly||5.37%||Relative Volume||141.44%||Average Volume||81.7 K|
|New High||New Low|
|30-day SEC yield||Average market capitalization||Average weighted market capitalization||51.95 B||Forward P/E||14.22|
|Gross expense ratio||Index dividend yield||2.82||Median market cap||Number of holdings||1299|
|Price to Book Value||1.59||Price to Earnings||Total expense ratio||0.34%||Total net assets|
|Weighted market capitalization|
|Index Dividend Yield||2.82|
|Fy1 P/E Ratio||14.22|
|Number Of Holdings||1299|
|Average Weighted Market Capitalization||51951.71|
|Total Expense Ratio||0.34|
|Roche Holding Ltd Genusssch.||1.23|
|Hsbc Holdings Plc||1.04|
|Samsung Electronics Co. Ltd. Gdr Regs||0.96|
|Toyota Motor Corp.||0.94|
|Royal Dutch Shell Plc Class A||0.84|
2016-09-30 08:04:27 | Teva Has a Targeted Strategy to Expand in Major Growth Markets
2016-09-28 11:05:25 | Teva’s Commercial Strategy May Be Successful across Europe
2016-09-27 10:04:36 | This Strategy Could Boost Teva’s Growth Prospects Even More
2016-08-29 11:30:51 | These ETFs Offer Value As Global Markets Grind On
2016-08-23 11:04:05 | Will Anda Acquisition Improve Access to Teva’s Generic Drugs?
2016-04-13 01:04:56 | Teva Pharmaceutical: Label Expansion Plans in 2016
2016-04-04 11:08:04 | How Is Teva Aiming to Lead the Abuse-Deterrent Opioid Segment?
2016-03-30 15:44:54 | How Will Teva Benefit from Its Multiple Acquisitions?
2016-01-19 17:06:29 | Teva’s Debt Position and Valuations
2015-12-14 13:20:55 | FEZ and EWJ Fall as Crude Oil Prices Plunge Further
2015-12-09 17:54:00 | DuPont-Dow Megadeal Talk Stirs Materials ETFs
2015-12-09 08:06:31 | Kite Pharma Leads IBB’s Mid-Caps on Its Zuma-1 Phase 1 Results
2015-12-08 18:56:00 | Oil ETFs Dig A Hole But Could Syria Change That?
2015-12-08 13:06:33 | Consumer Staples Didn’t Fall into Equity Market’s Downtrend
2015-12-08 13:03:47 | SPY Ended Negative as Oil Sank to New Lows
2015-12-08 12:07:52 | Alexion Tops IBB’s Large-Caps on Release of New Research Data
2015-12-07 18:13:00 | Jet ETF Climbs, Dow In Red For 2015 As Oil Weighs
2015-12-07 17:34:05 | Financial Sector Catches a Rate Hike Tailwind on December 4
2015-12-07 17:34:00 | Gung-Ho US Employment Scene Catapults SPY on December 4
2015-12-07 15:45:31 | How Are IBB’s American Depositary Receipts Performing?
2015-12-04 07:00:00 | A Low-Cost Way to Bet on Banking
2015-11-25 11:12:07 | 3 Big Market Movers This Week
2015-11-05 19:47:28 | U.S.-based stock funds attract $5.7 bln in latest week -Lipper
2015-09-13 21:40:00 | Is The U.S. Economy Going To Crash This Year?